| scholarly article | Q13442814 |
| P50 | author | Saphy Sharda | Q88825007 |
| Sanjeev Kumar Singh | Q89694482 | ||
| Anuraj Nayarisseri | Q50731575 | ||
| Mallika Alvala | Q83009376 | ||
| P2093 | author name string | Srinivas Bandaru | |
| Hema Prasad Mundluru | |||
| Himshikha Goud | |||
| P2860 | cites work | Managing asthma exacerbations in the emergency department: summary of the National Asthma Education And Prevention Program Expert Panel Report 3 guidelines for the management of asthma exacerbations | Q84394564 |
| Continuous versus intermittent beta-agonists for acute asthma | Q24247701 | ||
| Clinical review: severe asthma | Q24537771 | ||
| A summary of the new GINA strategy: a roadmap to asthma control | Q26799984 | ||
| Conserved Binding Mode of Human β 2 Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography | Q27663654 | ||
| Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths | Q28244453 | ||
| Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy | Q28251042 | ||
| Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes | Q29397708 | ||
| SIFT: Predicting amino acid changes that affect protein function | Q29547211 | ||
| Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group | Q49092631 | ||
| Ergostatting and thermostatting at a fixed point. | Q51079905 | ||
| Association of Beta 2 adrenergic receptor (Thr164Ile) polymorphism with Salbutamol refractoriness in severe asthmatics from Indian population. | Q51621059 | ||
| Reversible multiple time scale molecular dynamics | Q56157167 | ||
| Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems | Q56750591 | ||
| Physics-based enzyme design: predicting binding affinity and catalytic activity | Q56893550 | ||
| British Guideline on the Management of Asthma | Q57415778 | ||
| Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K | Q57831509 | ||
| Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticus | Q70961005 | ||
| Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects | Q72956092 | ||
| Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes | Q81708937 | ||
| Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007 | Q29615702 | ||
| STRUM: structure-based prediction of protein stability changes upon single-point mutation | Q30389520 | ||
| Adverse effects of high-dose epinephrine on cerebral blood flow during experimental cardiopulmonary resuscitation | Q30874271 | ||
| How ephedrine escaped regulation in the United States: A historical review of misuse and associated policy | Q33649270 | ||
| Treatment of acute asthma. A new look at the old and at the new. | Q33977294 | ||
| Beta-2 adrenergic receptor (ADRB2) gene polymorphisms and the risk of asthma: a meta-analysis of case-control studies | Q34028227 | ||
| Heterogeneity of therapeutic responses in asthma | Q34255472 | ||
| Collective judgment predicts disease-associated single nucleotide variants | Q34354991 | ||
| Beta2-adrenoceptors: mechanisms of action of beta2-agonists | Q34562278 | ||
| Beta-adrenoceptor agonists and asthma--100 years of development | Q34686510 | ||
| Global strategy for asthma management and prevention: GINA executive summary. | Q34731997 | ||
| Adverse effects of beta-agonists | Q35016429 | ||
| Pharmacology and physiology of human adrenergic receptor polymorphisms | Q35050594 | ||
| Pharmacological management to reduce exacerbations in adults with asthma: a systematic review and meta-analysis | Q35841905 | ||
| Therapeutic responses in asthma and COPD. Bronchodilators | Q35859729 | ||
| Past, present and future--beta2-adrenoceptor agonists in asthma management | Q36044251 | ||
| Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. | Q36255673 | ||
| Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone | Q36452490 | ||
| The 1990 Lilly Prize Lecture. A way of looking at agonism and antagonism: lessons from salbutamol, salmeterol and other beta- adrenoceptor agonists | Q36516893 | ||
| Asthma mortality and inhaled beta agonist therapy | Q36538842 | ||
| PredictSNP: robust and accurate consensus classifier for prediction of disease-related mutations | Q37487954 | ||
| Perioperative considerations for the patient with asthma and bronchospasm | Q37653106 | ||
| Are beta2-agonists responsible for increased mortality in heart failure? | Q37906050 | ||
| Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application | Q38023611 | ||
| Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma | Q39374605 | ||
| ProTherm, version 2.0: thermodynamic database for proteins and mutants | Q39541303 | ||
| Identification of Small Molecule as a High Affinity β2 Agonist Promiscuously Targeting Wild and Mutated (Thr164Ile) β 2 Adrenergic Receptor in the Treatment of Bronchial Asthma. | Q39769881 | ||
| Prediction of the stability of protein mutants based on structural environment-dependent amino acid substitution and propensity tables | Q40914387 | ||
| Predicting functional effect of human missense mutations using PolyPhen-2. | Q42406410 | ||
| A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor | Q42490743 | ||
| Cell signalling: Binding the receptor at both ends | Q42939989 | ||
| Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol: a randomized controlled trial | Q43614613 | ||
| The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s). | Q43715261 | ||
| β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies | Q44008986 | ||
| A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists | Q44385450 | ||
| Selective inhibition of relaxation of guinea-pig trachea by charybdotoxin, a potent Ca(++)-activated K+ channel inhibitor | Q46840377 | ||
| ADRB2 polymorphisms and asthma susceptibility: transmission disequilibrium test and meta-analysis | Q47577319 | ||
| The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin | Q47682341 | ||
| Medications and Recent Patents for Status Asthmaticus in Children | Q47987211 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rac-salbutamol | Q410358 |
| P304 | page(s) | e0186666 | |
| P577 | publication date | 2017-10-20 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Molecular dynamic simulations reveal suboptimal binding of salbutamol in T164I variant of β2 adrenergic receptor | |
| P478 | volume | 12 |
| Q95728318 | An In silico Approach to Identify High Affinity Small Molecule Targeting m-TOR Inhibitors for the Clinical Treatment of Breast Cancer |
| Q92758994 | Design of PD-L1 inhibitors for lung cancer |
| Q92758944 | Design of novel JAK3 Inhibitors towards Rheumatoid Arthritis using molecular docking analysis |
| Q90102159 | Differential Dynamics Underlying the Gln27Glu Population Variant of the β2-Adrenergic Receptor |
| Q92758962 | FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia |
| Q92876929 | Identification of High-Affinity Small Molecule Targeting IDH2 for the Clinical Treatment of Acute Myeloid Leukemia |
| Q90284778 | Identification of Potent VEGF Inhibitors for the Clinical Treatment of Glioblastoma, A Virtual Screening Approach |
| Q92758972 | Virtual Screening of IL-6 Inhibitors for Idiopathic Arthritis |
Search more.